News | Treatment Planning | September 08, 2015

First U.S. Patient Treated With Brainlab’s Automatic Brain Metastases Planning Software

Technology reduced treatment time for five tumors from three hours to under 20 minutes

Brainlab, Automatic Brain Metastases Planning software, first U.S. patient, Jefferson Hospital for Neuroscience, Philadelphia

September 8, 2015 — Brainlab announced that its Automatic Brain Metastases Planning software has been used for the first time in the United States at Jefferson Hospital for Neuroscience in Philadelphia. The software was used to deliver a tailored radiosurgery treatment to a patient with cancer that has metastasized to the brain. The procedure, in which all five of the patient’s brain metastases were treated, took less than 20 minutes, including setup time using the Brainlab technology. Using the traditional method, it could have taken three hours or roughly 30 minutes per tumor.

When treating such patients, Automatic Brain Metastases Planning offers improvements over the current standard of whole brain radiation therapy (WBRT) treatment. WBRT involves applying low doses of radiation to the entire brain over time and with many sessions, which can lead to cognitive deficits. Automatic Brain Metastases Planning software can automatically render a clinically ready treatment plan typically in less than two minutes.

Using a unique dedicated algorithm, the Brainlab software allows delivery of highly conformal single-session treatments while helping to minimize dose spread to surrounding healthy tissue. By treating multiple brain metastases at one time, planning and treatment time can be significantly reduced, even with as many as 10 tumors to treat.  

“In our first patient treatment, we targeted five metastatic brain tumors in one frameless treatment session,” commented David W. Andrews, M.D., professor in the Department of Neurosurgery, director of the Division of Neuro-oncologic Neurosurgery and Stereotactic Radiosurgery. “We will continue to use the Brainlab software with ExacTrac patient positioning and monitoring to efficiently and effectively treat up to 10 metastatic tumors at once, helping prevent unnecessary loss of brain function that can occur with whole brain radiation therapy, such as memory loss or other cognitive deficits.”

"With traditional stereotactic radiosurgery techniques, each metastasis is planned and treated individually, thereby increasing treatment time,” said Wenyin Shi, M.D., Ph.D., assistant professor of radiation oncology, medical director of radiation oncology at Jefferson Hospital for Neurosciences, and co-director of the Jefferson Brain Tumor Program. “The Brainlab software allows us to deliver a conformal cranial SRS plan with time-efficient precision targeting of several metastases in a single session.”

“Patients with diseases that cause brain lesions often require multiple treatments that are lengthy and cause discomfort. We are enthusiastic about any advances in practice that can limit the time a patient needs to undergo treatment and minimalize distress,” added Andrews.

Automatic Brain Metastases Planning is part of the Brainlab Elements a la carte software modules that support and facilitate neurosurgery and radiation oncology treatment planning

For more information: www.brainlab.com

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.